🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to evaluate and compare the side effects and a...
Status
Completed
Location
Novartis Investigative Site
Start Date
2000-06
Trial ID
NCT00333840
Treatments Being Tested
This study evaluates the combination of entacapone and imatinib in the trea...
Status
Completed
Location
Bin Li, MD
Start Date
2020-10-30
Trial ID
NCT04006769
Treatments Being Tested
This study is composed of Phase I and Phase II part. Phase I part: The obje...
Status
Completed
Location
Local Institution
Start Date
2005-07
Trial ID
NCT00337454
The aim of this study is to demonstrate that in subjects with moderate to s...
Status
Recruiting
Location
The First Affiliated Hospital of USTC Anhui Provincial Hospital
Start Date
2024-11-20
Trial ID
NCT06682169
Treatments Being Tested
The purpose of this study is to evaluate treatment-free remission after ima...
Status
Completed
Location
Centro de Hematologia e Hemoterapia - Universidade Estadual de Campinas
Start Date
2016-06-22
Trial ID
NCT02852486
Treatments Being Tested
This study proposes to evaluate the number of chronic, Grade 1 or 2, non-he...
Status
Completed
Location
Pacific Cancer Medical Center
Start Date
2012-12
Trial ID
NCT01660906
Treatments Being Tested
This is a phase III study of BMS-354825 in subjects with chronic phase Phil...
Status
Completed
Location
University Of Alabama At Birmingham
Start Date
2005-07
Trial ID
NCT00123474
This phase II trial is studying how well combination chemotherapy with or w...
Status
Completed
Location
Children's Oncology Group
Start Date
2002-10
Trial ID
NCT00022737
Treatments Being Tested
A randomized controlled pilot study on the safety \& efficacy of imatinib f...
Status
Unknown
Location
Multiple Locations
Start Date
2020-06
Trial ID
NCT04422678
Treatments Being Tested
This trial was a Phase I/II, non-randomized, open label, multi-center study...
Status
Completed
Location
Dana Farber Cancer Institute Dept of Sarcoma Oncology
Start Date
2002-11-13
Trial ID
NCT01275222